The transcriptome profile of human trisomy 21 blood cells
- PMID: 33933170
- PMCID: PMC8088681
- DOI: 10.1186/s40246-021-00325-4
The transcriptome profile of human trisomy 21 blood cells
Abstract
Background: Trisomy 21 (T21) is a genetic alteration characterised by the presence of an extra full or partial human chromosome 21 (Hsa21) leading to Down syndrome (DS), the most common form of intellectual disability (ID). It is broadly agreed that the presence of extra genetic material in T21 gives origin to an altered expression of genes located on Hsa21 leading to DS phenotype. The aim of this study was to analyse T21 and normal control blood cell gene expression profiles obtained by total RNA sequencing (RNA-Seq).
Results: The results were elaborated by the TRAM (Transcriptome Mapper) software which generated a differential transcriptome map between human T21 and normal control blood cells providing the gene expression ratios for 17,867 loci. The obtained gene expression profiles were validated through real-time reverse transcription polymerase chain reaction (RT-PCR) assay and compared with previously published data. A post-analysis through transcriptome mapping allowed the identification of the segmental (regional) variation of the expression level across the whole genome (segment-based analysis of expression). Interestingly, the most over-expressed genes encode for interferon-induced proteins, two of them (MX1 and MX2 genes) mapping on Hsa21 (21q22.3). The altered expression of genes involved in mitochondrial translation and energy production also emerged, followed by the altered expression of genes encoding for the folate cycle enzyme, GART, and the folate transporter, SLC19A1.
Conclusions: The alteration of these pathways might be linked and involved in the manifestation of ID in DS.
Keywords: Blood cells; Down syndrome; Human chromosome 21; RNA sequencing; Transcriptome; Trisomy 21.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21.BMC Med Genet. 2006 Mar 15;7:24. doi: 10.1186/1471-2350-7-24. BMC Med Genet. 2006. PMID: 16539728 Free PMC article.
-
Potential interaction between the GARS-AIRS-GART Gene and CP2/LBP-1c/LSF transcription factor in Down syndrome-related Alzheimer disease.Cell Mol Neurobiol. 2007 Dec;27(8):1117-26. doi: 10.1007/s10571-007-9217-2. Epub 2007 Sep 28. Cell Mol Neurobiol. 2007. PMID: 17902044
-
Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells.Front Genet. 2018 Apr 24;9:125. doi: 10.3389/fgene.2018.00125. eCollection 2018. Front Genet. 2018. PMID: 29740474 Free PMC article.
-
Mouse models of Down syndrome: gene content and consequences.Mamm Genome. 2016 Dec;27(11-12):538-555. doi: 10.1007/s00335-016-9661-8. Epub 2016 Aug 18. Mamm Genome. 2016. PMID: 27538963 Free PMC article. Review.
-
On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.Brain Res Brain Res Rev. 2001 Apr;35(2):115-45. doi: 10.1016/s0926-6410(00)00074-4. Brain Res Brain Res Rev. 2001. PMID: 11336779 Review.
Cited by
-
Gene Expression Studies in Down Syndrome: What Do They Tell Us about Disease Phenotypes?Int J Mol Sci. 2024 Mar 4;25(5):2968. doi: 10.3390/ijms25052968. Int J Mol Sci. 2024. PMID: 38474215 Free PMC article. Review.
-
Transcriptome research of human amniocytes identifies hub genes associated with developmental dysplasia in down syndrome.Aging (Albany NY). 2023 Dec 12;15(23):14086-14108. doi: 10.18632/aging.205291. Epub 2023 Dec 12. Aging (Albany NY). 2023. PMID: 38095646 Free PMC article.
-
Integration of ATAC-seq and RNA-seq identifies MX1-mediated AP-1 transcriptional regulation as a therapeutic target for Down syndrome.Biol Res. 2023 Dec 9;56(1):67. doi: 10.1186/s40659-023-00474-x. Biol Res. 2023. PMID: 38066591 Free PMC article.
-
Transcription dosage compensation does not occur in Down syndrome.BMC Biol. 2023 Nov 10;21(1):228. doi: 10.1186/s12915-023-01700-4. BMC Biol. 2023. PMID: 37946204 Free PMC article.
-
Transcriptomic analysis of stem cells from chorionic villi uncovers the impact of chromosomes 2, 6 and 22 in the clinical manifestations of Down syndrome.Stem Cell Res Ther. 2023 Sep 23;14(1):265. doi: 10.1186/s13287-023-03503-4. Stem Cell Res Ther. 2023. PMID: 37740230 Free PMC article.
References
-
- Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A, for the National Birth Defects Prevention Network Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008–1016. doi: 10.1002/bdra.20735. - DOI - PubMed
-
- Strippoli P, Pelleri MC, Piovesan A, Caracausi M, Antonaros F, Vitale L. Genetics and genomics of Down syndrome. Int Rev Res Dev Disabil. 2019;56:1–39. doi: 10.1016/bs.irrdd.2019.06.001. - DOI
-
- Lejeune J, Gauthier M, Turpin R. Human chromosomes in tissue cultures. Comptes rendus hebdomadaires des seances de l’Academie des sciences. 1959;248(4):602–603. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases